1 results match your criteria: "University of California at Los Angeles School of Medicine 90095-1738[Affiliation]"
MUSE therapy: preliminary clinical observations.
Urology
November 1997
Department of Urology, University of California at Los Angeles School of Medicine 90095-1738, USA.
Objectives: Intracavernosal injection of vasodilating agents has been a mainstay in the treatment of erectile dysfunction. Recently, a transurethral delivery system (MUSE) for alprostadil (prostaglandin E1) was introduced as an alternative form of pharmacotherapy.
Methods: One hundred consecutive patients with erectile dysfunction were treated with MUSE in doses ranging from 125 to 1000 micrograms and their erections were observed in the clinical setting.